multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
although
precis
etiolog
ms
remain
unclear
cell
propos
play
effector
also
regulatori
role
ms
cell
divid
four
subset
proinflammatori
helper
th
cell
antiinflammatori
cell
regulatori
cell
treg
role
cell
ms
clarifi
either
lossoffunct
gainoffunct
method
conduct
mainli
autoimmun
viral
model
ms
experiment
autoimmun
encephalomyel
eae
theiler
murin
encephalomyel
viru
tmev
infect
respect
observ
ms
patient
consist
mechan
found
ms
model
increas
proinflammatori
activ
associ
diseas
exacerb
antiinflammatori
cell
treg
appear
play
protect
role
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
correal
fiol
jaff
glabu
kelley
minagar
kira
immun
cell
particularli
b
cell
implic
pathogenesi
ms
johnson
suidan
mcdole
pirko
sato
omura
martinez
tsunoda
base
express
antigen
cell
divid
two
subpopul
cell
rotteveel
et
al
cell
recogn
extracellular
intracellular
antigen
present
major
histocompat
complex
mhc
class
ii
molecul
respect
tabl
cell
help
cellular
humor
immun
cell
function
cytotox
lymphocyt
ctl
tabl
tissu
cell
type
shown
express
mhc
class
molecul
surfac
mhc
class
ii
molecul
express
mainli
antigenpres
cell
apc
dendrit
cell
dc
macrophag
tabl
hand
rest
cn
four
major
parenchym
neuron
cell
neuron
oligodendrocyt
astrocyt
microglia
shown
express
neither
mhc
class
mhc
class
ii
molecul
upon
apc
antigenpres
cell
activ
howev
astrocyt
microglia
express
mhc
class
ii
molecul
oligodendrocyt
express
mhc
class
molecul
mhc
class
ii
molecul
neuron
express
mhc
class
ii
molecul
condit
joli
oldston
pender
suzumura
lavi
weiss
silberberg
collect
activ
glial
cell
label
gliosi
activ
astrocyt
microglia
term
astrogliosi
astrocytosi
microgliosi
respect
note
term
prolifer
accur
cn
parenchym
cell
neuron
postmitot
cell
even
glial
cell
increas
number
mitot
activ
microglia
astrocyt
chang
morpholog
express
molecul
process
visual
histolog
exampl
microglia
activ
lectin
cytochemistri
astrocyt
activ
immunohistochemistri
glial
fibrillari
acid
protein
gfap
tsunoda
mccright
kuang
zurbriggen
fujinami
activ
astrocyt
microglia
also
express
immunerel
molecul
proinflammatori
cytokin
includ
interleukin
il
tumor
necrosi
factor
tnf
cytokin
typic
produc
lymphocyt
interferon
ifn
thu
term
neuroinflamm
often
use
describ
convent
inflammatori
cn
diseas
also
sever
cn
neurolog
diseas
tradit
categor
noninflammatori
parkinson
diseas
chen
tansey
alzheim
diseas
stroke
latter
diseas
lesion
contain
littl
extravas
cellular
humor
compon
blood
vessel
parenchym
lymphocyt
infiltr
bloodbrain
barrier
bbb
breakdown
activ
microglia
astrocyt
shown
present
adjac
lesion
exampl
alzheim
diseas
term
chronic
inflamm
vascular
inflamm
use
descript
condit
immunerel
molecul
adhes
molecul
proinflammatori
cytokin
upregul
blood
vessel
microglia
astrocyt
without
extravas
leukocyt
blood
vessel
gramma
note
demyelin
observ
major
neuroimmunopatholog
find
neuroinflammatori
diseas
patholog
term
inflamm
defin
condit
occur
tissu
manifest
rubor
red
calor
heat
tumor
swell
dolor
pain
mainli
caus
extravas
blood
cell
serum
compon
associ
vasodilat
kumar
abba
fausto
aster
note
howev
term
inflamm
often
use
describ
system
cn
diseas
atherosclerosi
extravas
leukocyt
occur
upregul
immunerel
molecul
vagu
usag
term
inflamm
drawn
attent
role
immunerel
molecul
diseas
tradit
defin
noninflammatori
howev
easili
confus
diseas
true
inflammatori
diseas
immun
cell
extravas
blood
vessel
parenchyma
play
major
role
thu
chapter
use
term
inflamm
condit
blood
leukocyt
extravas
blood
vessel
addit
avoid
confus
neuroinflamm
compos
mainli
astrogliosi
microgliosi
versu
tradit
inflamm
extravas
leukocyt
circul
cn
parenchyma
occur
use
term
gliosi
former
term
neuroinflamm
chapter
section
follow
although
activ
astrocyt
microglia
alon
suffici
induc
demyelin
activ
microglia
may
associ
trigger
subsequ
inflammatori
demyelin
earli
lesion
ms
anim
model
microgli
nodul
small
area
microgliosi
observ
sato
tanaka
hasanov
tsunoda
singh
et
al
tsunoda
tanaka
saijoh
fujinami
interestingli
earli
lesion
contain
demyelin
often
demonstr
axon
degener
andor
oligodendrocyt
apoptosi
thu
microgliosi
preced
demyelin
fullblown
demyelin
shown
requir
recruit
leukocyt
system
circul
particularli
cell
clinic
cours
ms
classifi
four
form
lublin
reingold
tsunoda
kuang
theil
fujinami
relapsingremit
rr
primari
progress
pp
secondari
progress
sp
progressiverelaps
pr
rrm
defin
diseas
attack
relaps
full
recoveri
remiss
minim
sequela
sospedra
martin
major
ms
patient
develop
rrm
initi
follow
spm
character
progress
neurolog
deficit
eber
ppm
patient
progress
continu
onset
without
remiss
noseworthi
lucchinetti
rodriguez
weinshenk
prm
progress
diseas
onset
acut
relaps
without
full
recoveri
period
relaps
character
continu
progress
although
precis
pathomechan
ms
remain
unclear
etiolog
ms
associ
genet
autoimmun
environment
factor
particularli
viral
infect
sato
omura
et
al
clinic
studi
shown
genet
factor
contribut
pathogenesi
ms
lynch
et
al
pugliatti
sotgiu
rosati
schwendimann
alekseeva
seboun
et
al
haplotyp
human
leukocyt
antigen
hla
posit
correl
ms
develop
dyment
eber
sadovnick
gene
includ
receptor
chain
receptor
chain
tnf
receptor
may
influenc
risk
develop
ms
oksenberg
baranzini
barcello
hauser
oksenberg
baranzini
sawcer
hauser
rose
gene
vitamin
receptor
fukazawa
et
al
estrogen
receptor
niino
kikuchi
fukazawa
yabe
tashiro
also
link
ms
suscept
howev
individu
genet
background
alway
develop
ms
concord
ms
among
monozygot
twin
diseas
incid
greater
seen
dizygot
twin
eber
et
al
autoimmun
theori
ms
base
detect
myelinspecif
cell
antibodi
ms
patient
burn
bartholomew
lobo
histolog
infiltr
immun
cell
includ
cell
observ
activ
ms
lesion
hafler
weiner
clinic
immunomodulatori
drug
glatiram
acet
antiveri
late
antibodi
tysabri
natalizumab
shown
suppress
diseas
activ
rrm
patient
unlik
autoimmun
diseas
howev
neither
autoantigenspecif
cell
antibodi
respons
use
biomark
diagnosi
prognosi
ms
addit
although
mani
autoimmun
diseas
shown
accompani
primari
immunodefici
diseas
pid
eg
increas
lupuslik
diseas
complement
defici
ms
associ
pid
alherz
et
al
environment
factor
particularli
viral
infect
also
associ
ms
pathogenesi
deuschl
bode
heuser
schmider
ludwig
haas
et
al
clinic
sever
virus
herp
simplex
viru
human
herpesviru
coronaviru
isol
ms
patient
murray
brown
brian
cabirac
opsahl
kennedi
sander
et
al
addit
higher
immun
respons
certain
virus
epsteinbarr
viru
measl
viru
report
ms
patient
compar
healthi
control
chiodi
sunqvist
link
norrbi
christensen
lunemann
et
al
howev
neither
singl
viru
virusspecif
immun
respons
uniformli
detect
ms
patient
experiment
two
anim
model
ms
experiment
autoimmun
encephalomyel
eae
theiler
murin
encephalomyel
viru
tmev
infect
wide
use
autoimmun
viral
model
ms
respect
bahk
kappel
rasmussen
kim
clatch
melvold
miller
lipton
rodriguez
leibowitz
david
tsunoda
fujinami
two
model
resembl
ms
clinic
histolog
eae
model
shown
mediat
cell
induc
subcutan
inject
sensit
cn
antigen
spinal
cord
homogen
myelin
basic
protein
mbp
myelin
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
eae
model
recapitul
clinic
aspect
ms
sjlj
mice
develop
relapsingremit
eae
rreae
plp
plp
sensit
sobel
tuohi
lu
laursen
lee
tuohi
lu
sobel
laursen
lee
mice
develop
monophas
sustain
eae
without
complet
remiss
relaps
progress
mog
sensit
mendel
kerlero
de
rosbo
bennun
asw
mice
develop
primari
progress
eae
ppeae
without
remiss
tsunoda
et
al
tsunoda
libbey
kuang
terri
fujinami
intracerebr
inject
tmev
mice
induc
biphas
diseas
acut
phase
tmev
infect
week
post
infect
pi
mice
develop
acut
eae
recov
complet
chronic
phase
approxim
month
pi
mice
develop
inflammatori
demyelin
viral
persist
spinal
cord
suscept
tmevinduc
demyelin
diseas
tmevidd
shown
differ
among
mous
strain
sjlj
mice
suscept
tmevidd
develop
chronic
progress
paralysi
without
remiss
mice
clear
viru
resist
tmevidd
pullen
park
miller
dal
canto
kim
divers
immun
factor
includ
cell
antibodi
shown
play
either
pathogen
protect
role
tmevidd
sato
omura
et
al
mosmann
et
al
origin
classifi
cell
two
subset
helper
th
cell
two
subset
cell
cell
regulatori
cell
treg
note
regulatori
cell
commonli
abbrevi
treg
instead
treg
cell
identifi
bettelli
oukka
kuchroo
depend
transcript
factor
regul
distinct
cytokin
milieu
cell
differenti
four
subset
produc
distinct
cytokin
sato
omura
et
al
tabl
induc
transcript
factor
tbox
human
tbox
express
cell
tbet
mice
lead
differenti
cell
cell
produc
larg
amount
mediat
cellular
immun
respons
includ
delayedtyp
hypersensit
dth
clearanc
intracellular
pathogen
enhanc
express
transcript
factor
gata
bind
protein
human
mice
promot
differenti
cell
cell
produc
larg
amount
help
humor
immun
respons
antibodi
product
specif
cytokin
releas
cell
respect
suppress
cell
cell
express
transcript
factor
retinoicacidreceptorrel
orphan
receptor
c
rorc
human
mice
promot
differenti
cell
treg
express
transcript
factor
forkhead
box
human
mice
promot
differenti
treg
baecherallan
balanc
transform
growth
factor
tgf
act
induc
either
cell
produc
shown
play
role
antibacteri
fungal
immun
well
immunemedi
tissu
damag
immunopatholog
cytokin
releas
cell
suppress
cell
cytokin
inhibit
differenti
cell
treg
produc
suppress
th
cell
function
particularli
autoimmun
antitumor
immun
suppress
autoimmun
protect
antitumor
immun
detriment
host
matsui
et
al
immunoregulatori
axi
compos
four
subset
cell
propos
play
either
pathogen
protect
role
ms
cell
contribut
either
pathogenesi
protect
ms
cn
cell
recogn
myelin
antigen
present
mhc
class
ii
molecul
activ
microglia
astrocyt
cnsinfiltr
immun
cell
oligodendrocyt
neuron
tabl
antigen
recognit
cell
produc
cytokin
cell
produc
proinflammatori
cytokin
cell
treg
produc
antiinflammatori
cytokin
theoret
releas
proinflammatori
cytokin
recruit
inflammatori
cell
cn
enhanc
inflamm
damag
oligodendrocyt
axon
result
demyelin
axon
degener
proinflammatori
cytokin
shown
directli
indirectli
induc
apoptosi
oligodendrocyt
vitro
selmaj
rain
farooq
norton
brosnan
vartanian
li
zhao
stefansson
turn
apoptot
oligodendrocyt
degener
axon
activ
microglia
macrophag
exacerb
immunopatholog
although
antiinflammatori
tregassoci
cytokin
produc
cell
propos
suppress
immunopatholog
weber
hohlfeld
zamvil
cytokin
particularli
cytokin
also
enhanc
autoantibodi
product
ulusoy
et
al
contribut
tissu
damag
demyelin
model
system
cn
damag
like
caus
indirect
attack
solubl
molecul
direct
cellular
contact
cytotox
cell
sato
tanaka
et
al
theori
inflamm
cn
induc
demyelin
interestingli
howev
limit
number
antigen
virus
ie
myelin
antigen
virus
tmev
known
induc
demyelin
clinic
uncommon
cn
microbi
inflammatori
diseas
result
demyelin
except
includ
acut
dissemin
eae
relat
diseas
experiment
also
rare
nonmyelin
antigen
induc
demyelin
cn
derfuss
et
al
mathey
et
al
immunoregulatori
axi
proinflammatori
cell
antiinflammatori
cell
oppos
propos
regul
pathogenesi
ms
theori
support
clinic
studi
ms
immun
respons
posit
associ
diseas
activ
ms
patient
hofman
et
al
hofman
hinton
baemayr
weil
merril
merril
et
al
report
cell
line
deriv
cerebrospin
fluid
csf
ms
patient
produc
larger
amount
mechanist
although
exacerb
ms
administr
initi
seem
support
theori
panitch
hirsch
haley
johnson
panitch
hirsch
schindler
johnson
result
trial
controversi
sever
reason
similar
descript
find
ms
patient
observ
autoimmun
model
ms
eae
exampl
cell
isol
cn
peripheri
eae
mice
shown
preferenti
produc
cytokin
includ
ando
clayton
kono
urban
sercarz
merril
et
al
mechanist
pathogen
role
cell
eae
investig
mainli
lossoffunct
approach
use
gene
knockout
ko
mice
blockad
cytokin
neutral
antibodi
constantinescu
et
al
demonstr
prophylact
treatment
neutral
monoclon
antibodi
mab
render
suscept
sjlj
mice
resist
eae
induc
mous
spinal
cord
homogen
moginduc
eae
tbetdefici
mice
develop
less
sever
eae
lower
amount
product
compar
wildtyp
mice
bettelli
et
al
adopt
transfer
vitro
activ
expand
cell
mice
use
test
encephalitogen
transfer
cell
popul
passiv
eae
myelin
antigenspecif
cell
shown
induc
eae
upon
transfer
ando
et
al
baron
madri
ruddl
hashim
janeway
merril
et
al
viral
model
ms
tmevidd
inconsist
find
role
cell
earli
chronic
phase
tmev
infect
dth
respons
tmev
mainli
mediat
cell
associ
demyelin
miller
et
al
late
chronic
phase
tmev
infect
myelinspecif
cell
induc
epitop
determin
spread
viral
epitop
myelin
epitop
propos
exacerb
demyelin
diseas
miller
et
al
although
epitop
spread
detect
group
mechanist
although
inou
et
al
demonstr
inject
neutral
mab
earli
chronic
phase
tmev
infect
attenu
tmevidd
decreas
product
effect
modul
tmevidd
differ
depend
experiment
set
tsunoda
fujinami
cell
may
play
protect
role
ms
immun
respons
shown
increas
remiss
rrm
araki
et
al
clerici
et
al
decreas
diseas
progress
exacerb
ms
pregnanc
associ
immun
respons
alshammri
et
al
although
exact
mechan
remain
unclear
suppress
ms
diseas
activ
immunomodulatori
drug
glatiram
acet
also
associ
enhanc
immun
respons
weber
et
al
experiment
cell
shown
regul
eae
tmevidd
eae
induc
mous
spinal
cord
homogen
inject
neutral
mab
induct
phase
render
resist
balbc
mice
suscept
eae
constantinescu
et
al
adopt
transfer
plpspecif
cell
clone
time
sensit
diseas
onset
prevent
eae
mice
sensit
plp
kuchroo
et
al
cell
immunoglobulin
mucindomain
contain
tim
shown
preferenti
express
surfac
cell
neg
regul
immun
respons
blockad
ligand
interact
administr
solubl
fusion
protein
delay
onset
decreas
sever
plpinduc
eae
enhanc
immun
respons
chakravarti
et
al
tmevidd
immun
respons
also
demonstr
suppress
inflammatori
demyelin
cn
hill
et
al
demonstr
earli
chronic
phase
tmev
infect
infect
mice
treat
develop
less
sever
inflammatori
demyelin
compar
control
thu
find
eae
tmevidd
suggest
cell
could
contribut
pathogenesi
ms
cell
may
play
protect
role
tabl
depend
diseas
stage
model
cell
shown
play
benefici
detriment
role
anim
model
ms
eae
ferber
et
al
demonstr
mice
develop
sever
mbpinduc
eae
compar
suscept
wildtyp
mice
tran
et
al
demonstr
wildtyp
balbc
mice
resist
mbpinduc
eae
receptordefici
balbc
mice
develop
inflammatori
demyelin
cn
moreov
willenborg
et
al
willenborg
et
al
demonstr
lack
receptor
render
eaeresist
sv
mous
strain
suscept
moginduc
eae
tmevidd
acut
phase
tmev
infect
cell
seem
contribut
viral
clearanc
sinc
neutral
mab
significantli
acceler
onset
tmevidd
pullen
miller
dalcanto
van
der
meid
kim
unlik
convent
monophas
eae
rreae
model
diseas
cours
progress
eae
model
associ
immun
respons
lafail
et
al
demonstr
adopt
transfer
mbpspecif
cell
caus
progress
eae
immunocompromis
recombinationactiv
defici
mice
celldefici
mice
wildtyp
mice
immun
respons
may
also
exacerb
eae
enhanc
pathogen
autoantibodi
product
mog
tsunoda
et
al
demonstr
mogsensit
asw
mice
mount
high
antimog
antibodi
respons
immun
respons
extens
demyelin
immunoglobulin
ig
deposit
cn
result
progress
fatal
eae
furthermor
moginduc
eae
apoptot
cell
inject
sjlj
mice
alter
diseas
cours
rreae
secondari
progress
eae
speae
enhanc
antimog
antibodi
product
immun
respons
tsunoda
libbey
et
al
similarli
speae
model
induc
mog
sensit
ultraviolet
uv
irradi
sjlj
mice
speae
develop
sever
demyelin
diseas
higher
antimog
antibodi
respons
lower
immun
respons
compar
control
sjlj
mice
rreae
irradi
uv
tsunoda
kuang
igeng
fujinami
thu
case
ms
cell
may
play
protect
role
cell
may
associ
diseas
progress
paradigm
identifi
novel
immunoregulatori
axi
compos
proinflammatori
cell
antiinflammatori
treg
cell
promot
inflamm
proinflammatori
cytokin
chemokin
express
neutrophil
recruit
martinez
et
al
although
precis
role
cell
immunemedi
tissu
damag
remain
unclear
report
investig
effector
mechan
cell
ms
patient
rrm
number
cell
csf
higher
relaps
remiss
brucklacherwaldert
stuerner
kolster
wolthausen
tolosa
suggest
immun
respons
associ
diseas
activ
ms
patient
increas
messeng
rna
protein
level
detect
csf
peripher
blood
mononuclear
cell
pbmc
brain
lesion
ms
patient
particularli
relaps
lock
et
al
matuseviciu
et
al
tzarto
et
al
addit
nuclear
receptor
subfamili
group
member
control
cell
function
via
signal
shown
increas
cell
pbmc
ms
patient
doi
et
al
raveney
oki
yamamura
increas
frequenc
cell
eae
support
effector
role
cell
ms
hofstett
et
al
first
demonstr
product
detect
splenic
cell
eae
mice
sensit
mog
mice
follow
vitro
stimul
mog
neutral
protein
mab
partial
amelior
eae
similarli
komiyama
et
al
report
moginduc
eae
mice
show
delay
onset
decreas
sever
eae
compar
wildtyp
mice
addit
upon
passiv
transfer
wildtyp
mice
cell
mogsensit
wildtyp
mice
induc
eae
recipi
mice
higher
incid
mogsensit
mice
raveney
et
al
demonstr
inject
sirna
onset
moginduc
eae
reduc
molecul
includ
express
receptor
result
less
sever
clinic
sign
bettelli
et
al
demonstr
tg
mice
enhanc
product
cell
higher
frequenc
cell
develop
sever
moginduc
eae
wildtyp
mice
tmevidd
hou
et
al
found
percentagenumb
cell
among
cn
mononuclear
cell
mnc
higher
tmevsuscept
sjlj
mice
tmevresist
mice
suggest
detriment
role
cell
cnsinfiltr
mnc
produc
tmevinfect
sjlj
mice
tmevinfect
mice
follow
vitro
tmev
antigen
stimul
neutral
mab
inject
tmevinfect
sjlj
mice
inhibit
viral
persist
cn
enhanc
function
ctl
tmev
result
reduc
incid
sever
tmevidd
known
promot
cell
differenti
well
inflamm
tmevinfect
mice
produc
human
control
mhc
class
promot
show
clinic
sign
find
increas
viral
load
immun
respons
tmev
cn
hou
jin
kang
kim
thu
cell
could
play
pathogen
role
ms
tabl
treg
shown
contribut
mainten
immunolog
toler
suppress
autoreact
lymphocyt
due
product
antiinflammatori
cytokin
human
mice
shown
develop
autoimmun
diseas
immun
dysregul
polyendocrinopathi
enteropathi
xlink
ipex
syndrom
scurfi
mice
respect
sakaguchi
yamaguchi
nomura
ono
ziegler
interestingli
howev
note
mslike
cn
diseas
neither
report
ipex
syndrom
scurfi
mice
clinic
pbmc
ms
patient
treg
present
lower
number
function
defect
oh
et
al
viglietta
baecherallan
weiner
hafler
experiment
blockad
treg
mab
shown
exacerb
eae
montero
et
al
demonstr
mab
inject
prior
mog
sensit
exacerb
eae
find
increas
mogspecif
antibodi
respons
reddi
et
al
also
demonstr
blockad
treg
mab
render
resist
mice
suscept
plpinduc
eae
system
mab
treatment
increas
incid
eae
enhanc
inflamm
cn
higher
lower
product
cell
compar
control
antibodi
treatment
howev
caution
use
interpret
data
antibodi
studi
sinc
express
treg
also
activ
cell
clinic
treatment
antibodi
zenapax
daclizumab
report
therapeut
effect
ms
reduc
popul
activ
cell
although
treatment
reduc
number
function
treg
oh
et
al
pfender
martin
experiment
treatment
mab
also
inhibit
passiv
eae
model
donor
encephalitogen
cell
popul
stimul
mbp
presenc
mab
vitro
transfer
recipi
anim
hayosh
swanborg
result
show
mab
treatment
could
suppress
immun
effector
cell
function
human
anim
furthermor
cell
develop
thymu
express
wide
use
development
marker
murin
doubl
neg
dn
cell
godfrey
kennedi
suda
zlotnik
roifman
rothenberg
yui
howev
potenti
effect
antibodi
treatment
cell
develop
never
discuss
studi
hand
kohm
et
al
demonstr
recipi
mice
transfer
intraven
treg
day
eae
induct
show
significantli
less
clinic
sign
compar
recipi
mice
transfer
nontreg
cell
addit
coinject
mog
specif
cell
treg
suppress
develop
passiv
eae
recipi
mice
transfer
mog
specif
cell
alon
nontreg
cell
induc
sever
eae
similarli
selvaraj
geiger
demonstr
induc
treg
itreg
induc
presenc
vitro
inhibit
moginduc
eae
itreg
given
mice
onset
eae
vitro
mog
stimul
mnc
eae
mice
inject
itreg
higher
level
mogspecif
product
lower
level
product
compar
eae
mice
inject
pb
nontreg
cell
although
precis
immunosuppress
mechan
treg
remain
unclear
product
treg
shown
critic
immunosuppress
eae
model
treg
mice
fail
prevent
eae
recipi
mice
selvaraj
geiger
yu
et
al
zhang
et
al
contrast
tmevidd
detriment
role
treg
suggest
richard
et
al
tmev
infect
number
treg
cn
rapidli
increas
suscept
sjlj
mice
resist
mice
blockad
treg
mab
chronic
phase
tmev
infect
sjlj
mice
decreas
clinic
sign
tmevidd
hand
martinez
karlsson
et
al
demonstr
treg
play
detriment
also
protect
role
tmevidd
administ
itreg
tmevinfect
sjlj
mice
differ
time
point
sjlj
mice
treat
itreg
day
initi
tmev
infect
itregearli
itregearli
sjlj
mice
show
sever
clinic
sign
higher
cn
viral
load
acut
phase
tmev
infect
compar
untreat
control
mice
sinc
itregearli
sjlj
mice
less
immun
cell
infiltr
cn
acut
phase
tmev
infect
compar
control
mice
itreg
appear
suppress
cn
recruit
antivir
immun
cell
result
increas
cn
viral
load
itregearli
sjlj
mice
contrast
sjlj
mice
treat
itreg
late
phase
tmev
infect
itregl
itregl
sjlj
mice
develop
less
cn
inflammatori
demyelin
greater
amount
product
compar
untreat
control
mice
produc
multipl
cell
type
includ
cell
b
cell
macrophag
dc
consist
find
treg
could
induc
product
cell
type
anghelina
zhao
trandem
perlman
kearley
barker
robinson
lloyd
contrast
effect
itreg
tmev
infect
suggest
treg
could
benefici
suppress
immunopatholog
cn
viral
load
low
itregl
seen
persist
viral
infect
treg
could
detriment
suppress
antivir
immun
viral
replic
activ
itregearli
acut
viral
infect
thu
treg
could
play
benefici
detriment
role
depend
diseas
stage
tabl
describ
role
th
cell
subset
investig
mainli
use
lossoffunct
approach
although
studi
inform
mimic
human
treatment
immunosuppress
therapi
gainoffunct
mutat
human
immun
system
report
alter
immun
respons
includ
th
cell
subset
increas
suscept
sever
inflammatori
diseas
well
infect
exampl
hemolyt
urem
syndrom
chronic
mucocutan
candidiasi
yamazaki
et
al
report
rais
question
whether
genet
enhanc
th
cell
subset
could
affect
suscept
inflammatori
demyelin
diseas
ms
establish
tbet
mice
overexpress
tbet
cell
immun
respons
respect
mous
background
tabl
ishizaki
et
al
yoh
et
al
yoh
et
al
induc
eae
tmevidd
wildtyp
litterm
tg
mice
system
wildtyp
mice
develop
monophas
eae
mog
sensit
resist
tmevidd
expect
eae
mice
develop
sever
cn
demyelin
lesion
compar
wildtyp
mice
martinez
sato
omutra
et
al
tmev
infect
mice
develop
inflammatori
demyelin
cn
figur
c
compar
suscept
sjlj
mice
figur
resist
mice
demyelin
figur
b
hand
mice
show
delay
onset
moginduc
eae
less
sever
clinic
sign
compar
wildtyp
mice
mice
remain
resist
tmevidd
wildtyp
mice
interestingli
tbettg
mice
neither
develop
eae
tmevidd
martinez
sato
omutra
et
al
sato
fernando
et
al
thu
genet
bia
toward
one
th
cell
subset
could
lead
distinct
effect
suscept
inflammatori
demyelin
diseas
depend
etiolog
autoimmun
versu
viral
infect
cell
exhaust
loss
cell
function
number
demonstr
chronic
viral
infect
human
immunodefici
viru
hepat
c
viru
hepat
b
viru
lymphocyt
choriomening
viru
lcmv
well
patient
malign
melanoma
lung
cancer
speiser
et
al
wherri
cell
exhaust
studi
mainli
cell
also
report
cell
yi
cox
zajac
process
continu
high
antigen
stimul
propos
caus
follow
chang
initi
virusspecif
cell
produc
multipl
cytokin
includ
gradual
lose
abil
eikawa
mizukami
udono
cell
first
lose
abil
produc
follow
later
produc
cytokin
yi
et
al
prolif
abil
well
cell
repertoir
number
virusspecif
cell
also
shown
decreas
time
antivir
immun
respons
also
decreas
due
increas
apoptosi
antivir
cell
lead
increas
viral
load
activ
marker
express
antivir
cell
lselectin
receptor
downregul
express
inhibitori
receptor
cell
includ
program
cell
death
lymphocyteactiv
cytotox
tlymphocyt
antigen
upregul
addit
inhibitori
receptor
antiinflammatori
cytokin
well
treg
play
role
cell
exhaust
yi
et
al
cell
develop
sequenc
event
detriment
host
lead
increas
viral
load
cancer
growth
one
teleolog
idea
regard
reason
exhaust
evolv
limit
immunopatholog
wherri
concept
cell
exhaust
question
salek
ardakani
schoenberg
speiser
et
al
exampl
hosk
flynn
botten
whitton
show
mice
immun
lcmv
phenomenon
describ
cell
exhaust
observ
occur
rapidli
within
h
second
challeng
lcmv
hierarch
loss
multipl
cytokin
respons
earli
termin
product
upregul
inhibitori
molecul
slight
increas
cell
apoptosi
although
cell
appear
exhaust
lose
antivir
ctl
activ
ctl
respons
evalu
vivo
ctl
assay
cell
retain
granzym
b
upregul
retain
cytolyt
activ
cell
observ
like
ctl
assay
conduct
ex
vivo
vitro
situat
ctl
respons
occur
often
barber
wherri
ahm
select
cell
suppress
call
split
exhaust
cell
retain
benefici
antivir
ctl
function
suppress
potenti
harm
product
induc
immunopatholog
suggest
phenomenon
describ
cell
exhaust
may
physiolog
transit
function
special
adapt
cell
keep
benefici
function
prevent
immunopatholog
speiser
et
al
although
one
may
argu
physiolog
function
split
exhaust
appear
good
true
similar
split
function
observ
treg
wherri
studi
treg
shown
suppress
immunopatholog
without
suppress
antivir
immun
respons
thu
without
increas
viral
load
describ
howev
benefici
outcom
treg
depend
time
cours
viral
infect
martinez
karlsson
et
al
found
suppress
immunopatholog
tmevidd
itreg
associ
unclear
whether
itreg
induc
split
exhaust
cell
either
directli
indirectli
exampl
suppress
product
cell
yi
et
al
inhibitori
receptor
induc
upon
activ
mani
type
immun
cell
includ
cell
b
cell
natur
killer
cell
monocyt
dc
zhao
li
leak
chen
hu
two
bide
ligand
program
cell
death
ligand
also
call
also
call
member
famili
costimulatori
molecul
constitut
express
cell
b
cell
macrophag
dc
phare
et
al
express
mainli
restrict
apc
includ
macrophag
dc
b
cell
zhong
tumang
gao
bai
rothstein
human
express
low
undetect
rest
cn
tissu
express
induc
particularli
astrocyt
microglia
upon
activ
although
express
inconclus
cn
resid
cell
express
report
lower
brain
endotheli
cell
ms
patient
healthi
control
addit
ms
lesion
cell
express
major
cell
express
thu
ms
lesion
interact
may
impair
lead
exacerb
immunopatholog
experiment
defici
blockad
interact
shown
exacerb
anim
model
ms
salama
et
al
demonstr
express
progress
increas
cn
eae
induct
mog
blockad
mab
exacerb
eae
increas
infiltr
cell
cn
follow
vitro
mog
stimul
product
higher
splenic
mnc
eae
mice
treat
mab
untreat
control
mice
furthermor
carter
et
al
demonstr
mice
mice
develop
sever
moginduc
eae
wildtyp
mice
increas
product
proinflammatori
cytokin
includ
mnc
isol
drain
lymph
node
similar
eae
level
express
increas
cours
tmev
infect
tmevidd
blockad
interact
enhanc
proinflammatori
cytokin
product
cnsinfiltr
cell
result
exacerb
clinic
sign
without
alter
cn
viral
load
duncan
miller
takizawa
et
al
thu
engag
may
associ
suppress
ms
howev
experi
investig
role
rule
effect
immun
cell
eae
tmevidd
express
mani
type
immun
cell
cell
although
describ
preferenti
express
cell
cell
also
express
activ
cell
microglia
dc
lee
goverman
interact
ligand
shown
suppress
cell
function
rodriguezmanzanet
dekruyff
kuchroo
umetsu
clinic
express
lower
cell
clone
isol
csf
ms
patient
healthi
control
express
defect
cell
ms
patient
hafler
kuchroo
koguchi
et
al
experiment
blockad
interact
use
antibodi
exacerb
plpinduc
eae
monney
et
al
tmevidd
kaneyama
et
al
found
express
increas
diseas
cours
mice
inject
neutral
mab
develop
sever
clinic
sign
compar
control
mice
thu
interact
could
also
associ
suppress
ms
sever
effector
regulatori
mechan
play
pathogen
role
cellmedi
immunopatholog
may
detriment
host
simpli
induc
wrong
place
wrong
time
point
tabl
physiolog
condit
convent
infect
mainten
cellspecif
respons
without
cell
exhaust
vital
high
level
antibodi
product
ctl
respons
howev
cell
respons
play
detriment
role
respons
prolong
induc
patholog
condit
cn
autoimmun
persist
cn
infect
viru
evad
immun
respons
infect
mhc
neg
cell
immun
privileg
sitein
cn
lack
regular
lymphat
system
presenc
bbb
block
convent
cellular
antibodi
immun
respons
respect
similarli
epitop
determin
spread
ie
phenomenon
cell
respons
direct
initi
one
epitop
later
direct
multipl
epitop
propos
enhanc
immunopatholog
sever
immunemedi
diseas
includ
ms
rheumat
heart
diseas
tabl
guilherm
kalil
cunningham
lehmann
forsthub
miller
sercarz
epitop
spread
may
lead
recoveryprotect
immunemedi
diseas
powel
black
furthermor
physiolog
benefici
role
epitop
spread
propos
microbi
infect
malign
spread
epitop
occur
epitop
pathogen
tumor
antigen
contribut
effici
clearanc
microb
tumor
tabl
butterfield
et
al
powel
black
interact
among
cell
appear
crucial
pathophysiolog
ms
anim
model
cours
rrm
cell
produc
proinflammatori
cytokin
play
effector
role
immunemedi
tissu
damag
immunopatholog
wherea
cell
treg
produc
antiinflammatori
cytokin
suppress
immunopatholog
hand
immun
respons
may
also
play
pathogen
role
develop
spm
enhanc
autoantibodi
product
treg
doubleedg
sword
depend
stage
viral
infect
treg
play
benefici
role
virusmedi
demyelin
diseas
prevent
immunopatholog
treg
enhanc
viral
patholog
suppress
antivir
immun
respons
cell
subset
ideal
control
split
cell
exhaust
immunopatholog
prevent
without
suppress
antivir
cell
respons
person
modul
cell
subset
may
therapeut
strategi
individu
ms
patient
whose
etiolog
autoimmun
versu
viral
clinic
cours
rr
versu
progress
diseas
stage
earli
late
relaps
remiss
etc
may
differ
